Lakovos Nomikos | Health Professions | Outstanding Scientist Award

Prof. Dr. Lakovos Nomikos | Health Professions | Outstanding Scientist Award

MD, PhD, FACS from European University Cyprus Nicosia Cyprus, Rea Maternity Hospital Athens Greece, Greece

Dr. Iakovos N. Nomikos, MD, PhD, FACS, is a distinguished academic surgeon with over four decades of experience in clinical practice, research, and medical education. Born on October 1, 1951, in Greece, Dr. Nomikos has dedicated his career to advancing surgical science, with particular contributions in the fields of transplantation biology, metabolic support for critical illness, and oncologic surgery. He has held significant roles in both academic and hospital settings, including Assistant Professor and Chairman of Surgery at major institutions. His extensive training includes fellowships in the United States and the United Kingdom, reflecting a broad international perspective and collaboration. Dr. Nomikos is a Fellow of the American College of Surgeons and a respected member of multiple medical societies. His work spans a wide range of clinical and research domains, and he is widely recognized for his mentorship, leadership, and commitment to the integration of scientific innovation into surgical practice. His contributions have been presented in international conferences, lectures, and numerous publications in both Greek and English literature. Dr. Nomikos continues to serve as an adjunct professor, influencing the next generation of medical professionals while remaining actively engaged in clinical and academic research.

Professional Profile

Education

Dr. Iakovos N. Nomikos pursued his early education at the “Gymnasium” High School in Syros, Cyclades, Greece, from 1963 to 1969, graduating with excellence. He then entered the Medical School of Athens University, where he studied from 1969 to 1975. His academic record was exemplary, achieving an “excellency” degree. The medical program at Athens University included an integrated internship in the final year, consisting of clinical rotations in internal medicine, surgery, pediatrics, and obstetrics-gynecology. This foundational training provided him with a solid grounding in multiple medical disciplines. Following his medical degree, Dr. Nomikos completed a residency in General Surgery at “Evagelismos” Medical Center in Athens from 1975 to 1980. His postgraduate education continued through prestigious fellowships in surgical nutrition, transplantation biology, critical care, and hepatobiliary surgery at world-renowned institutions such as the University of Colorado Health Sciences Center, New York Medical College, and The Queen Elizabeth Hospital in Birmingham, England. These advanced studies and international experiences significantly enriched his clinical knowledge and research capabilities, positioning him as a leader in surgical education and innovation. His diverse academic training has underpinned a career defined by scientific inquiry, clinical excellence, and global collaboration.

Professional Experience

Dr. Nomikos’s professional career spans several decades, marked by progressive responsibility and distinction in surgical practice and academic leadership. His early career began with positions as an attending surgeon at Evangelismos Medical Center and Larissa General Hospital in Greece. From 1987 to 2004, he served in the Department of Surgery at Tzanion General Hospital, Piraeus, progressing from attending surgeon to associate director. In 2004, he was appointed Chairman of Surgery at Metaxa Cancer Memorial Hospital, where he served until 2018, overseeing clinical operations, research, and resident education. Since 2019, he has continued practicing surgery in the private sector at Rea Maternity Hospital and Metropolitan General Hospital in Athens. In parallel with his clinical duties, Dr. Nomikos has held academic positions, including Lecturer and Assistant Professor of Surgery at Athens University and currently serves as Adjunct Professor of Surgery at the European University of Cyprus. His teaching responsibilities span both the School of Medicine and the Department of Life Sciences. Throughout his career, he has played a vital role in shaping surgical education programs and mentoring young professionals. His leadership has consistently integrated evidence-based practice with clinical innovation, reinforcing his reputation as a pillar of surgical excellence in Greece and beyond.

Research Interests

Dr. Iakovos N. Nomikos has cultivated a robust and diverse research portfolio throughout his career, combining basic science with applied clinical studies. His early research focused on transplantation biology, with particular emphasis on pancreatic islet transplantation for insulin-dependent diabetes mellitus (IDDM), examining graft destruction mechanisms. He has also extensively studied ischemia-reperfusion injury, a critical area in transplantation and trauma surgery. Another major area of interest includes the cellular biology of peritonitis, where he has investigated immune response and inflammation in abdominal infections. In applied research, Dr. Nomikos has addressed practical clinical challenges such as peritoneal infections, neo-adjuvant chemotherapy for solid tumors, metabolic responses in critically ill surgical patients, and functional staging of acute surgical illness. His interest in surgical metabolism and nutrition has informed clinical protocols that improve recovery and outcomes in post-operative and intensive care settings. These research interests not only highlight his interdisciplinary approach but also reflect a commitment to enhancing surgical care through scientific advancement. Dr. Nomikos’s work stands at the intersection of innovation and clinical relevance, aiming to translate laboratory discoveries into improved patient outcomes. His efforts have contributed significantly to the fields of surgical oncology, critical care, and transplant medicine.

Research Skills

Dr. Nomikos brings an exceptional set of research skills developed through decades of clinical practice, international training, and academic scholarship. His expertise spans both bench-side experimentation and bedside clinical research. In basic science, he is skilled in experimental models of islet transplantation, immunological assays, and the study of cellular mechanisms involved in ischemia-reperfusion injury and peritonitis. His training in the United States and the UK equipped him with advanced competencies in surgical research methodologies, including critical care and transplant-related studies. In clinical research, he excels in protocol development, data analysis, clinical trial execution, and outcome evaluation, particularly in surgical oncology and critical care settings. He has led and participated in projects focusing on chemotherapy protocols, surgical metabolic support, and the functional assessment of acute surgical conditions. Dr. Nomikos is also adept at medical writing, scientific presentation, and research mentoring, contributing significantly to academic publications, oral communications, and educational leadership. His ability to bridge theoretical science with surgical practice exemplifies translational research at its best. These multifaceted skills have enabled him to drive innovations in patient care, guide clinical decision-making, and mentor a generation of surgeon-scientists within Greece and internationally.

Awards and Honors

Dr. Iakovos N. Nomikos has received numerous honors and awards in recognition of his exceptional contributions to surgery, research, and education. He is a Fellow of the American College of Surgeons (FACS), a prestigious international credential that signifies excellence in surgical practice and ethics. His career achievements have been acknowledged through several institutional, national, and international recognitions, including leadership positions in major hospitals and academic programs. He has been honored for his work in surgical oncology, critical care, and transplantation science. Dr. Nomikos’s scholarly efforts have been consistently featured in leading international congresses, where he has delivered invited lectures, chaired roundtable discussions, and presented scientific exhibits. His teaching accomplishments have also been recognized by academic institutions where he has played a pivotal role in curriculum development and resident training. Moreover, his influence extends through professional societies, where he holds memberships that reflect both his scientific stature and dedication to interdisciplinary collaboration. These accolades collectively underscore a career marked by lifelong service to advancing surgical science and mentoring future generations of clinicians. His awards affirm his lasting impact on both the academic and medical communities, validating his status as a respected leader in the global surgical field.

Conclusion

Dr. Iakovos N. Nomikos exemplifies the ideal candidate for recognition through a Research for Outstanding Scientist Award. His career is defined by a seamless integration of academic rigor, clinical excellence, and translational research. From pioneering studies in transplantation biology to practical innovations in critical care and oncologic surgery, he has consistently addressed key challenges in surgical practice through scientific inquiry. His mentorship, leadership, and continued contributions as an adjunct professor demonstrate ongoing relevance and impact. With a history of productive research collaborations, international training, and a strong publication and presentation record, Dr. Nomikos has significantly advanced both theoretical and applied surgical knowledge. Although further visibility through recent high-impact publications or patent disclosures could strengthen his profile, the depth, breadth, and longevity of his contributions are clear. He has made lasting advancements in patient care, surgical methodology, and medical education. In conclusion, Dr. Nomikos’s distinguished achievements over several decades merit recognition not only as a leading figure in his field but also as a scientist whose work has tangibly improved lives and enriched the broader medical community. His career is a model of what sustained excellence and dedication in clinical research can accomplish.

Publications Top Notes

  • Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice
    Authors: IN Nomikos, SJ Prowse, P Carotenuto, KJ Lafferty
    Journal: Diabetes, 35(11), 1302–1304
    Citations: 159
    Year: 1986

  • Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation
    Authors: R Omar, I Nomikos, G Piccorelli, J Savino, N Agarwal
    Journal: Gut, 30(4), 510–514
    Citations: 139
    Year: 1989

  • Involvement of O2 radicals in ‘autoimmune’ diabetes
    Authors: IN Nomikos, Y Wang, KJ Lafferty
    Journal: Immunology and Cell Biology, 67(1), 85–87
    Citations: 97
    Year: 1989

  • Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial
    Authors: IN Nomikos, K Katsouyanni, AN Papaioannou
    Journal: Surgery, 99(1), 20–25
    Citations: 64
    Year: 1986

  • Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice
    Authors: Y Wang, M McDuffie, IN Nomikos, L Hao, KJ Lafferty
    Journal: Transplantation, 46(2), 101S–106S
    Citations: 49
    Year: 1988

  • Current surgical aspects of palliative treatment for unresectable pancreatic cancer
    Authors: K Karapanos, IN Nomikos
    Journal: Cancers, 3(1), 636–651
    Citations: 28
    Year: 2011

  • Protective and damaging aspects of healing: A review
    Authors: IN Nomikos, C Malizos, NC Vamvakopoulos
    Journal: Wounds: A Compendium of Clinical Research and Practice, 18(7), 177–185
    Citations: 28
    Year: 2006

  • Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery
    Authors: N Perrakis, E Athanassiou, D Vamvakopoulou, M Kyriazi, H Kappos, …
    Journal: World Journal of Gastroenterology, 17(35), 4013
    Citations: 27
    Year: 2011

  • Carcinoma of the inguinal region arising from endometriosis of the round ligament. Report of a case
    Authors: J Elemenoglou, A Skopelitou, I Nomikos
    Journal: European Journal of Gynaecological Oncology, 14(1), 28–32
    Citations: 27
    Year: 1993

  • Tamoxifen-induced endometrial polyp. A case report and review of the literature
    Authors: IN Nomikos, J Elemenoglou, J Papatheophanis
    Journal: European Journal of Gynaecological Oncology, 392, 2936
    Citations: 23
    Year: 1998

Saeid Ferdousmakan | Health Professions | Best Researcher Award

Dr. Saeid Ferdousmakan | Health Professions | Best Researcher Award

Researcher at Nargund College of Pharmacy, Iran

Saied Ferdousmakan is a dedicated clinical pharmacist and researcher with a strong background in oncology, pharmacology, and medication safety. He earned his Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences, Bengaluru, India, where he focused on medication safety in obstetrics and gynecology. His research interests are centered on miRNA-based therapeutic strategies for cancer, particularly liver cancer and melanoma, as well as autophagy mechanisms and immunotherapies. Saied’s expertise is further enhanced by practical experience as a clinical pharmacist, having worked in both India and Iran. He is committed to advancing cancer research and therapeutic interventions, actively contributing to scientific literature through publications and conference presentations. Saied is also engaged in continuous professional development, attending workshops on topics like molecular biology, immunoinformatics, and oncology. His soft skills in leadership, communication, and public speaking add to his overall capability as a researcher and healthcare professional.

Professional Profile

Education:

Saied Ferdousmakan holds a Doctor of Pharmacy (PharmD) degree from Rajiv Gandhi University of Health Sciences in Bengaluru, India, where he completed his studies from July 2013 to May 2019. His academic journey was marked by a focus on pharmacy, where he earned a GPA of 2870 out of 4500, recognized as a first division. His PharmD thesis, titled Medication Safety in Obstetrics and Gynecology Ward in Jayanagar General Hospital, Bangalore, highlighted his commitment to improving healthcare practices. His education laid the foundation for his ongoing research in therapeutic strategies and clinical pharmacy.

Professional Experience:

Saied’s professional career spans clinical pharmacy and research. From January 2023 to March 2024, he worked as a Clinical Pharmacist at Daryan Hospital in Iran, where he provided direct patient care and contributed to medication management. Prior to this, he completed an internship at Jayanagar General Hospital in India from July 2019 to July 2020. His role involved enhancing patient care and improving safety protocols in the hospital’s general medicine department. This clinical experience has strengthened his practical understanding of drug therapy, which complements his research focus.

Research Interests:

Saied Ferdousmakan’s primary research interests lie in the design and application of miRNA-based therapies for cancer, with a special focus on liver cancer. His work investigates miR-148a-3p as a negative regulator of glycometabolism and cell proliferation in liver cancer cells. Additionally, he explores the role of Ambra1 protein in autophagy, which contributes to drug resistance and cancer progression, particularly in melanoma. Saied is also involved in studying immunotherapies targeting CTLA-4 and PD-1 in melanoma, as well as developing inhibitors like PKC and C-Met for treating uveal melanoma. His interest extends to stem cell research and using NOV/CCN3 proteins to enhance hematopoietic stem cell function, particularly in cord blood units.

Research Skills:

Saied possesses strong research skills in molecular biology, immunotherapy, and pharmacology. His expertise in designing miRNA-based therapeutic strategies and his understanding of cancer biology, particularly in melanoma and liver cancer, reflect his solid foundation in experimental design. He is proficient in laboratory techniques such as PCR, cell culture, and Western blotting, which are crucial for his studies in autophagy and drug resistance. Additionally, Saied is skilled in statistical analysis and the use of bioinformatics tools like R for analyzing complex datasets. His involvement in international research conferences further attests to his ability to communicate complex scientific findings to diverse audiences.

Awards and Honors:

While specific awards and honors are not explicitly listed, Saied has made significant contributions to research and academia, as evidenced by his publications in reputable journals such as Cancer Cell International and Pak. J. Med. Health Sci., as well as his presentations at international conferences. His ongoing research in cancer treatment and medication safety has been well-received in academic circles. Additionally, his active participation in professional workshops and continuous learning showcases his commitment to personal and professional growth. These factors, combined with his practical work experience and leadership abilities, suggest that Saied is on track for future recognition in his field.

Conclusion

Saied Ferdousmakan presents a strong candidacy for the Best Researcher Award based on his impactful research focus in oncology, a solid record of publications and presentations, and practical experience in clinical settings. His commitment to continuous education through specialized workshops and his exceptional soft skills contribute positively to his profile. Expanding his technical expertise and range of published research would further enhance his credentials. Overall, Saied is a promising researcher with substantial potential to make meaningful contributions to pharmacology and oncology.

Publication Top Notes

  1. Current understanding of epigenetics role in melanoma treatment and resistance
    • Authors: M Karami Fath, A Azargoonjahromi, A Soofi, F Almasi, S Hosseinzadeh, …
    • Year: 2022
    • Citation Count: 35
    • Source: Cancer Cell International, 22(1), 313
  2. Reactive oxygen species induced by SARS-CoV-2 infection can induce EMT in solid tumors: potential role of COVID-19 in chemo-resistance and metastasis
    • Authors: M Moulaeian, S Ferdousmakan, S Banihashemi, S Homayounfar, …
    • Year: 2024
  3. Evaluation of pulmonary bacterial infections in people exposed to mustard gas
    • Authors: SM Fathi, Farzam Nasirzadeh, Zahra, Ferdousmakan, Saeid, …
    • Year: 2022
  4. Medication Safety in Obstetrics and Gynecology Ward in Jayanagar General Hospital, Bangalore, India
    • Authors: S Ferdousmakan, N KB, M Etesami
    • Year: 2021
    • Source: Pakistan Journal of Medical and Health Sciences, 15(5), 1270-1275
  5. Medication Safety in Obstetrics and Gynecology Ward in Tertiary Care Hospital, Bangalore, India
    • Authors: M Etesami, S Sirisha, S Ferdousmakan
    • Year: 2020
    • Source: Archives of Pharmacy Practice, 11(1-2020), 81-86
  6. Evaluation of Herpes Simplex Virus Types 1 and 2 in Patients with Multiple Sclerosis
    • Authors: SF Shahkamali, SMG Dazmiri, N Amirebrahimi
    • Year: Not specified